Cargando…
Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
Liposomes have been long considered as a vaccine delivery system but this technology remains to be fully utilized. Here, we describe a novel liposome-based subunit vaccine formulation for tuberculosis (TB) based on phosphatidylserine encapsulating two prominent TB antigens, Ag85B, and ESAT-6. We sho...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598733/ https://www.ncbi.nlm.nih.gov/pubmed/31293568 http://dx.doi.org/10.3389/fimmu.2019.01349 |
_version_ | 1783430824832532480 |
---|---|
author | Diogo, Gil R. Hart, Peter Copland, Alastair Kim, Mi-Young Tran, Andy C. Poerio, Noemi Singh, Mahavir Paul, Matthew J. Fraziano, Maurizio Reljic, Rajko |
author_facet | Diogo, Gil R. Hart, Peter Copland, Alastair Kim, Mi-Young Tran, Andy C. Poerio, Noemi Singh, Mahavir Paul, Matthew J. Fraziano, Maurizio Reljic, Rajko |
author_sort | Diogo, Gil R. |
collection | PubMed |
description | Liposomes have been long considered as a vaccine delivery system but this technology remains to be fully utilized. Here, we describe a novel liposome-based subunit vaccine formulation for tuberculosis (TB) based on phosphatidylserine encapsulating two prominent TB antigens, Ag85B, and ESAT-6. We show that the resulting liposomes (Lipo-AE) are stable upon storage and can be readily taken up by antigen presenting cells and that their antigenic cargo is delivered and processed within endosomal cell compartments. The Lipo-AE vaccine formulation combined with the PolyIC adjuvant induced a mixed Th1/Th17-Th2 immune response to Ag85B but only a weak response to ESAT-6. An immunization regimen based on systemic delivery followed by mucosal boost with Lipo-AE resulted in the accumulation of resident memory T cells in the lungs. Most importantly though, when Lipo-AE vaccine candidate was administered to BCG-immunized mice subsequently challenged with low dose aerosol Mycobacterium tuberculosis, we observed a significant reduction of the bacterial load in the lungs and spleen compared to BCG alone. We therefore conclude that the immunization with mycobacterial antigens delivered by phosphatidylserine based liposomes in combination with Poly:IC adjuvant may represent a novel BCG boosting vaccination strategy. |
format | Online Article Text |
id | pubmed-6598733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65987332019-07-10 Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG Diogo, Gil R. Hart, Peter Copland, Alastair Kim, Mi-Young Tran, Andy C. Poerio, Noemi Singh, Mahavir Paul, Matthew J. Fraziano, Maurizio Reljic, Rajko Front Immunol Immunology Liposomes have been long considered as a vaccine delivery system but this technology remains to be fully utilized. Here, we describe a novel liposome-based subunit vaccine formulation for tuberculosis (TB) based on phosphatidylserine encapsulating two prominent TB antigens, Ag85B, and ESAT-6. We show that the resulting liposomes (Lipo-AE) are stable upon storage and can be readily taken up by antigen presenting cells and that their antigenic cargo is delivered and processed within endosomal cell compartments. The Lipo-AE vaccine formulation combined with the PolyIC adjuvant induced a mixed Th1/Th17-Th2 immune response to Ag85B but only a weak response to ESAT-6. An immunization regimen based on systemic delivery followed by mucosal boost with Lipo-AE resulted in the accumulation of resident memory T cells in the lungs. Most importantly though, when Lipo-AE vaccine candidate was administered to BCG-immunized mice subsequently challenged with low dose aerosol Mycobacterium tuberculosis, we observed a significant reduction of the bacterial load in the lungs and spleen compared to BCG alone. We therefore conclude that the immunization with mycobacterial antigens delivered by phosphatidylserine based liposomes in combination with Poly:IC adjuvant may represent a novel BCG boosting vaccination strategy. Frontiers Media S.A. 2019-06-12 /pmc/articles/PMC6598733/ /pubmed/31293568 http://dx.doi.org/10.3389/fimmu.2019.01349 Text en Copyright © 2019 Diogo, Hart, Copland, Kim, Tran, Poerio, Singh, Paul, Fraziano and Reljic. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Diogo, Gil R. Hart, Peter Copland, Alastair Kim, Mi-Young Tran, Andy C. Poerio, Noemi Singh, Mahavir Paul, Matthew J. Fraziano, Maurizio Reljic, Rajko Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG |
title | Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG |
title_full | Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG |
title_fullStr | Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG |
title_full_unstemmed | Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG |
title_short | Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG |
title_sort | immunization with mycobacterium tuberculosis antigens encapsulated in phosphatidylserine liposomes improves protection afforded by bcg |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598733/ https://www.ncbi.nlm.nih.gov/pubmed/31293568 http://dx.doi.org/10.3389/fimmu.2019.01349 |
work_keys_str_mv | AT diogogilr immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg AT hartpeter immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg AT coplandalastair immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg AT kimmiyoung immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg AT tranandyc immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg AT poerionoemi immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg AT singhmahavir immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg AT paulmatthewj immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg AT frazianomaurizio immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg AT reljicrajko immunizationwithmycobacteriumtuberculosisantigensencapsulatedinphosphatidylserineliposomesimprovesprotectionaffordedbybcg |